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Abstract
Background: Overweight and obesity in children and adults is a major public health concern. Emerging evidence
suggests dietary sodium intake may be associated with obesity. This systematic review and meta-analysis will aim to
(i) assess the relation between dietary sodium intake and measures of adiposity in children and adults and (ii)
examine the relation between sodium intake and sugar-sweetened beverage (SSB) consumption, which is a known
risk factor for obesity.
Methods/design: An electronic search will be conducted using Medline Complete, CINAHL, Scopus, Embase and
Cochrane central register of controlled trials (CENTRAL). The search strategy will identify published peer-reviewed
articles that report on dietary sodium and either a marker of adiposity or SSB consumption. Only human studies
(ages >1 year) in English will be included, and no limits will be placed on publication date. No restrictions will be
placed on the method of sodium intake assessment. Cross-sectional, prospective studies, and randomised
controlled trials with a duration of ≥3 months will be included. Studies with participants with renal disease, cancer,
type 1 diabetes or heart failure or who are pregnant will be excluded. To assess the quality of studies, the
Cochrane’s Collaboration tool for assessing risk of bias in randomised trials will be used for randomised controlled
trials (RCTs), and the modified Newcastle-Ottawa Scale will be used for cross-sectional and prospective studies.
Meta-analysis will be used to assess the relation of sodium intake with two primary outcomes: (i) BMI and body
weight in adults and BMI z-score in children and (ii) weight category (i.e. healthy weight vs. overweight/obese). For
any outcomes in which meta-analysis is not possible, we will present data as a systematic review. Findings will be
grouped and reported separately for children and adolescents (ages 1–17 years) and adults (ages >18 years).
Discussion: This review and meta-analysis will provide insight into the relation between dietary sodium intake and
overweight and obesity. This information can be used to inform public health policies which target population
sodium consumption.
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Background
In many countries, overweight and obesity in children
and adults is a major public health issue [1]. The conse-
quences of obesity are substantial and include adverse
health and psychological outcomes and increased eco-
nomic burden [2]. The accumulation of excess weight
during childhood is particularly concerning as it pro-
motes the early onset of chronic diseases, such as car-
diovascular disease and diabetes [3], and increases the
risk of being overweight and obese in adulthood [4].
Whilst the causes of obesity are complex and multifac-
torial, an overall unhealthy diet characterised by excess
energy is considered to be the cornerstone for excess
weight gain [5, 6].
Recently, a number of studies have emerged which sug-
gest that dietary sodium intake may be implicated in
weight gain. Studies in children [7–9] and adults [8, 10–12]
have reported positive associations between sodium intake
and a range of adiposity outcomes including BMI or in
the case of children BMI z-score, weight category, percent
body fat and abdominal obesity. Cross-sectional studies
conducted in children from the UK, USA and Australia
have shown dietary sodium intake is positively associated
with the consumption of energy-rich sugar-sweetened
beverages [13–15]. It has been postulated that this rela-
tionship may be due to the effects of sodium on thirst, as
experimental studies in both animals and humans show
increased fluid intake on a higher sodium diet [16, 17].
Reported associations between sodium intake and adi-
posity outcomes may be confounded by energy intake,
as foods high in sodium are often also high in energy.
However, it may also be the case that energy intake is a
mediating factor on the causal pathway between sodium
intake and obesity. The addition of sodium chloride
(salt) increases the palatability of many foods and en-
courages greater energy intake [18]. Moreover, it has
been suggested that salt may act as a vehicle that drives
intake of dietary fat. This is supported by reports which
show that attraction to salty-and-fatty foods are associ-
ated with higher total daily energy intakes in adults [19],
uncontrolled eating [20] and overweight in children [21].
Interestingly, some studies report an association be-
tween sodium intake and adiposity measures, which are
independent of energy intake [7–9]. In humans, an alter-
native mechanism which may explain this relationship
remains unclear. However, findings from animal studies
indicate that a diet high in sodium increases adipose tis-
sue mass, and this is due to changes in insulin and glu-
cose metabolism which favour fat accumulation [22, 23].
For example, in a study of male Wister rats, it was
shown that those rats who were fed a high sodium diet
had significant increases in adipose tissue mass from all
three sites of collection (i.e. subcutaneous, periepididy-
mal and retroperitoneal fat pads) at week 6 compared to
those rats fed a normal sodium diet; this was despite no
difference in energy intakes between the groups. How-
ever, by completion of the intervention (i.e. week 9),
there was no difference in adipose tissue mass between
the groups [22].
Given the ubiquity of sodium in the food supply [24],
it is important to understand if there are additional
health concerns of a high sodium diet, which go beyond
the traditional concerns of blood pressure and cardio-
vascular health [25]. To date, the emerging literature
surrounding dietary sodium intake and obesity has not
been systematically reviewed. This information can be
used to inform public health policy which relates to
population sodium reduction strategies.
Objective
The primary aim of this systematic review and meta-
analysis is to examine the relation between dietary so-
dium intake and measures of adiposity in children and
adults. The primary outcomes are (i) body weight and
BMI for adults and BMI z-score for children and adoles-
cents and (ii) weight category (i.e. ‘healthy weight’ vs.
‘overweight/obese’). Secondary outcomes for adiposity
measures include percent body fat and central obesity. A
secondary aim is to examine the relation between so-
dium intake and sugar-sweetened beverage consump-
tion, which is a known risk factor for obesity.
Methods/design
This protocol adheres to the Preferred Reporting Items
for Systematic Review and Meta-Analysis Protocols
(PRISMA-P) 2015 statement [26] (Additional file 1) and
was registered with the International Prospective Register
of Systematic Reviews (PROSPERO) (registration number
CRD42015016440).
Search strategy
An electronic literature search will be conducted using
four databases: Medline Complete (EBSCO Host),
CINAHL (EBSCO Host), Scopus, Embase and Cochrane
central register of controlled trials (CENTRAL). The
search strategy was developed in consultation with a re-
search librarian. Free text keywords were used to con-
duct the search. Medical subject headings (MeSH) were
considered in the development of the search terms. E.g.
the MeSH term ‘sodium chloride, dietary’ was included
as a keyword, therefore within the database Medline
Complete articles which include this term as a MeSH
Heading would be retrieved (Table 1). Search criteria
specific to each database are outlined in Table 2. The
search strategy was piloted across each database to im-
prove the effectiveness of the final search. Only peer-
reviewed original research articles published in English
and conducted in humans will be included. It is beyond
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the scope of this review to include and examine sources
from ‘grey’ literature. The risk of bias and threat to val-
idity by excluding unpublished studies will be discussed
within the final manuscript. The reference lists of in-
cluded studies identified through the search will also be
reviewed. Near the end of the review process, the search
will be rerun to identify any potential studies that have
been published since the initial search.
Eligibility criteria
Studies will be included if they report sodium intake and
either a measure of an adiposity outcome or sugar-
sweetened beverage (SSB) intake. Whilst the primary
outcome of this review is a marker of adiposity, we have
included SSB intake as a secondary outcome, as early
work identified SSBs as a potential mediating factor link-
ing sodium intake to obesity [15, 27]. SSBs will include
sugar-sweetened soda, vitamin waters, fruit ades, fruit
drinks, squash (i.e. cordial), flavoured mineral waters
and sports and energy drinks [28]. Studies that include
100 % fruit juice or sweetened tea or coffee within their
definition of SSB will be excluded.
The exposure outcome is dietary sodium intake, and
as 90 % of sodium is consumed in the form of sodium
chloride, the terms dietary salt and sodium chloride will
also be considered as exposure outcomes. Studies which
assess sodium intake via dietary method or via urinary
electrolyte analyses will be included. No restrictions will
be placed on the method of sodium intake assessment
(i.e. inclusion of dietary methods: dietary recalls, diet re-
cords and food frequency questionnaires; urinary elec-
trolyte assessment: 24-h urine, overnight, timed or spot
urine collections). Cross-sectional studies, prospective
Table 1 Search strategy
Search concept Search terms
Concept 1 (exposure) “sodium intake”
OR “sodium consumption”
OR “dietary sodium”
OR “sodium chloride intake”
OR “sodium chloride consumption”
OR “dietary sodium chloride”
OR “salt intake”
OR “salt consumption”
OR “dietary salt”
OR “sodium, dietary” (MeSH Heading)
OR “salt, dietary”
OR “sodium chloride, dietary” (MeSH Heading)
Concept 2 (outcome) “body weight” (MeSH Heading)
OR bmi
OR “body mass index” (MeSH Heading)
OR “bmi score”
OR “bmi z-score”
OR “bmi sds”
OR “body fat” (MeSH Heading)
OR “body fat percentage”
OR “% body fat”
OR “percent body fat”
OR “fat mass”
OR “bmi percentile”
OR obes*
OR overweight (MeSH Heading)
OR adipos*
OR “waist circumference” (MeSH Heading)
OR “waist circumference z-score”
OR “waist-to-height-ratio” (MeSH Heading)
OR “WHtR”
OR “centrally obese”
OR “central adiposity”
OR “body composition” (MeSH Heading)
OR “sugar-sweetened beverage”
OR “sugar-sweetened beverages”
Final search Concept 1 AND Concept 2
In Medline Complete, free text terms were also searched for
Table 2 Search criteria specifications for each database
Database Search options
Medline Completea via
EBSCOhost Research Databases
Limiters: English language, human
Search mode: Boolean/phrase
CINAHL via EBSCOhost
Research Databases
Limiters: English language, human,
peer reviewed
Search mode: Boolean/phrase
Scopus Limiters: English language; document
type: article
Search mode: Boolean/phrase
Embase Advanced search
No mapping options used
No date limits specified
Sources: Embase only (Medline not
selected as separate search)
Field labels: abstract, article title, index
term and subheading
Quick limits: human, only in English
Publication types: article, article in press
EBM, gender, age and animal advanced
options left blank
Cochrane Library Search: title, abstract, keywords
Limits: Cochrane central register of
controlled trials (CENTRAL)
aMedline Complete only includes peer-reviewed journals
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studies (with at least 1 year duration) and randomised
controlled trials (RCTs) will be included. Due to the
short-term effects of sodium reduction on extracellular
fluid loss and change in body weight, RCTs where the
salt reduction arm within the intervention has a dur-
ation of less than 3 months will be excluded. Weight loss
trials and weight maintenance studies, which are de-
signed to achieve weight loss, will be excluded as it
would not be possible to discern the effects of sodium
alone (i.e. a range of diet and/or lifestyle factors are gen-
erally targeted). In the case of salt reduction, RCTs
where there is more than one intervention arm under
investigation, for example a weight loss group, sodium
reduction only group and combined treatment group
(i.e. weight loss and sodium reduction), we will only ex-
tract data for the sodium reduction group and control
group (i.e. ‘usual care’) and exclude data from the weight
loss group. No restrictions will be placed on participants
who are taking antihypertensive medications within a
salt reduction intervention; however, information related
to diuretic use will be recorded in the data extraction
form. RCTs that specifically test the effects of diuretic
therapy will be excluded. Case control studies will be ex-
cluded. Infants, defined as <1 year of age will be ex-
cluded, and no other age restrictions will be applied.
Participants with renal disease, cancer, type 1 diabetes or
heart failure or who are pregnant will be excluded.
Study selection and data management
All papers identified from the initial electronic search
process will be imported into an endnote library, and
duplicates will be removed. Titles and abstracts will be
screened by two investigators. Studies will be included
based on the eligibility criteria as outlined above, and
discrepancies in opinion of studies to include at this stage
amongst the two reviewers will be resolved through con-
sultation with a third reviewer (CN). Following this
screening process, the full text of potential studies to in-
clude will be retrieved. Two independent reviewers will
screen at the full text stage according to the eligibility cri-
teria. Any discrepancies between the two reviewers for in-
cluded or excluded studies will be discussed, and if an
agreement cannot be reached, a third reviewer (CN) will
be used to reach consensus. The reason for excluding each
study will be recorded. At this stage, the reference lists of
included studies will be scanned, and if any relevant stud-
ies are identified, the full text will be retrieved and
reviewed for inclusion by both reviewers. Data extraction
of included studies will be completed by two independent
reviewers (CG, DB) using a data extraction template. The
template will include the following: author; title; journal;
year of publication; study setting; study design; study
population; sample size; participant demographic charac-
teristics; method used to assess sodium intake;
intervention details (where applicable), in children
methods used to calculate BMI z-score and define over-
weight and obesity (e.g. CDC vs. WHO BMI cut-offs);
study outcomes relevant to the aims of this review, i.e. so-
dium; and outcomes for adiposity measures or SSB con-
sumption, statistical analysis and confounder adjustment;
and funding source. The template will be piloted by both
reviewers, and if necessary, the information recorded will
be modified. Any disagreement between extracted data be-
tween each reviewer (CG, DB) will be discussed, and if an
agreement cannot be reached, a third reviewer (CN) will
provide input.
Quality assessment
The quality of studies included in this review will be
assessed by two researchers (CG and DB) using a tool
appropriate for the study design. Any discrepancies be-
tween the two reviewers will be discussed, and if a con-
sensus on study quality rating cannot be reached, advice
will be sought from a third reviewer (CN). For RCTs, the
Cochrane’s Collaboration tool for assessing risk of bias
in randomised trials [29] will be used. This tool includes
six domains to assess bias (i.e. selection bias, perform-
ance bias, detection bias, attrition bias and reporting
bias) which are assigned as either ‘low risk of bias’, ‘un-
clear risk of bias’ or ‘high risk of bias’ [29]. This infor-
mation will be presented as a risk of bias summary
figure using the Review Manager software (RevMan, ver-
sion 5.3). To assess the study quality of prospective and
cross-sectional studies, a modified version of the
Newcastle-Ottawa Scale (NOS) for cohort studies will be
used [30] (Additional file 2). The tool has been modified
to suit the context of studies that will be included in this
review, for example consideration is given to the meth-
odology used to determine sodium intake. This tool
assigns stars to indicate higher quality based on three
broad criteria, specific to the study design (i.e. selection
of study groups, comparability and outcome assess-
ment). This information will be presented in a summary
table, indicating the star rating for each individual study
included in the review. This process of quality assess-
ment will be completed by two independent reviewers
(CG, DB) for each study included in the review.
Data synthesis
The PRISMA flow chart [31] will be used to document
the number of studies identified during the search
process and those excluded and included according to
the outlined eligibility criteria. Random effects meta-
analysis methods will be used to assess the relation be-
tween sodium intake and the primary outcomes: (i) body
weight and BMI for adults and BMI z-score for chil-
dren/adolescents and (ii) weight category (i.e. ‘healthy
weight’, ‘overweight/obese’). All meta-analyses will be
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conducted separately for (i) adults (ages ≥18 years) and
children and adolescents (ages 1–17 years) and (ii) by
study design (i.e. RCTs, prospective and cross-sectional
studies). We anticipate that there will be a sufficient
number of cross-sectional studies to conduct a meta-
analysis for sodium intake and the primary outcomes;
however, the decision to complete a meta-analysis of
RCTs and prospective studies will be dependent on the
number of these types of studies identified in the review.
To conduct a meta-analysis, a minimum of two studies
will be required. The meta-analytical approach will be
dependent on the study design and is summarised below.
RCTs: In adults, the primary outcome will be body
weight, rather than BMI. This is because height remains
constant in pre- and post-studies and hence does not
need to be controlled for. In the case of RCTs in chil-
dren, due to growth changes, BMI z-score will remain as
the primary outcome. Meta-analysis will be used to cal-
culate the weighted mean difference (95 % CI) of change
in body weight/BMI z-score between reduced salt and
control group intervention arms. Where measures are
available at numerous time points, we will use data from
the latest time point available.
Prospective and cross-sectional studies: The primary
outcomes that will be assessed include BMI in adults,
BMI z-score in children and weight category for both
adults and children. For continuous outcomes (e.g. BMI
and BMI z-score), the pooled β coefficient (95 % CI) for
the association between salt intake and BMI/BMI z-score
will be reported. For dichotomous outcomes, the pooled
odds ratio (95 % CI) for the association between salt in-
take and weight category (i.e. healthy weight vs. over-
weight/obese) will be reported. Potential confounders (e.g.
age, sex, socio-economic status) will be accounted for by
using data from the most fully adjusted model (e.g. covari-
ates such as age, sex, socio-economic status) available.
Additional meta-analyses related to sodium intake and
other measures of adiposity (e.g. % body fat and central
obesity) will only be conducted if a sufficient number of
studies which report these outcomes are identified. With
reference to the secondary outcome, we anticipate that in
children and adolescents there will be enough cross-
sectional studies to conduct a meta-analysis to produce a
pooled β coefficient (95 % CI) estimate for the association
between sodium intake and SSB intake. Based on current
work in this area, it is anticipated that the level of sodium
exposure will be the equivalent of 1 g of salt per day and
its association with SSB intake (g/d). All data from the
meta-analyses will be displayed in forest plots. To assess
heterogeneity, we will use the Q statistic and I2 index. For
the Q statistic, a P value of <0.10 will be used as a cut-
point to indicate heterogeneity; however, consideration
will be given to the power of this test if only a few studies
and/or studies of small sample size are included in the
meta-analysis [32]. The degree of heterogeneity will be
assessed using the I2 index, and the following values will
be indicative of moderate (30–50 %), substantial (50–
75 %) and considerable heterogeneity (75–100 %) [32].
Potential heterogeneity will be explored by sub-group ana-
lysis, for example method of assessing salt intake, adjust-
ment for confounders and duration of intervention.
Funnel plots and Egger’s regression test will be used to as-
sess publication bias. All statistical analyses will be con-
ducted using STATA version 14 (Stata Corporation,
College Park, TX, USA). The Grading of Recommenda-
tions, Assessment, Development and Evaluation (GRADE)
framework will be applied to determine an overall evi-
dence rating for the two primary outcomes (BMI/BMI
z-score and weight category) included in the meta-
analyses [33]. This will be completed separately for adults
and children/adolescents. For any outcomes in which
meta-analysis is not possible, we will present data as a sys-
tematic review. These findings will be presented in sum-
mary tables according to the data extraction headings as
specified under the data management section. Findings
will be grouped and reported separately for children and
adolescents (ages 1–17 years) and adults (ages ≥18 years).
Discussion
This will be the first systematic review and meta-analysis
of studies to examine the association between dietary so-
dium intake and overweight and obesity, as well as so-
dium and sugar-sweetened beverage intake. Whilst it is
already recognised that a diet high in sodium increases
cardiovascular risk via the effects of raised blood pres-
sure [25], a greater understanding of any additional car-
diovascular risk due to adiposity is important for the
direction of public health policy that aims to lower
population sodium intake.
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